🇺🇸 FDA
Pipeline program

Oxandrolone

3822: POST-INJURY

Phase 3 small_molecule terminated

Quick answer

Oxandrolone for Trauma Injury is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Trauma Injury
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials